- Where are Leapfrog’s 11 straight-‘A’ hospitals?
- Where are Leapfrog’s 5 ‘F’ hospitals?
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS Health beats the Street with $2.9B in Q1 profit
- Rethinking DSOs: Challenging common misconceptions in modern dentistry
- WakeMed CEO says years of talks led to Atrium deal: ‘We’re the smallest health system of the competitive world now in North Carolina’
- 9 behavioral health facility and service closures, layoffs in 2026
- The new class of opioids: 4 things to know
- Maine health system unveils unified brand
- Physicians in Congress propose Medicare payment overhaul
- 2 men sentenced in $522M fraud, kickback scheme
- What 3 ASC leaders are saying about cardiology’s race to outpatient
- Hospital at home linked to better outcomes: 7 notes
- Long-established Florida physician practice acquired
- Facilitating Access to Trump Accounts
- HCA Tennessee hospital taps COO
- WellSpan Health to open 4-room ASC in Pennsylvania
- Colorado hospital names new CEO
- Yale New Haven hospital president to retire
- Ascension Tennessee hospital names COO
- Nurses fret AI overreliance could erode care, call for more guardrails
- Surgery Partners increases same-facility revenue by 4% in Q1: 10 notes
- Fixing Failures to Communicate
- Dr. Nisha D’Silva installed as president of the American Association for Dental, Oral and Craniofacial Research
- PDS Health, CareQuest partner to expand blood pressure screenings in dental offices
- 5 hospitals, health systems investing in ASCs
- Bankruptcy, PE debt and a $3.9B Ascension deal: A 30-year breakdown of AmSurg
- Henry Schein increases global dental sales by 9% in Q1: 7 notes
- Heartland Dental expands in 7 states
- Ohio woman charged with practicing unlicensed dentistry
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- 15 physician deals in 40 days
- Psych hospital eases security tool restrictions after violent incidents
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- TriHealth hospital hit with $10M verdict in psychiatric unit death
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- From 1st-in-state to 1st-in-world: 5 surgical milestones to know
- California hospitals sue Anthem over out-of-network care policy
- 3 dental mergers, acquisitions in April
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- HHS outlines plan to ‘curb psychiatric overprescribing’: 5 things to know
- Former Oklahoma dental assistant sentenced to prison for assaulting patients
- Statement on Proposing Semiannual Reporting
- Transforming Behavioral Healthcare Delivery through the Collaborative Care Model
- Wellstar partners with BD to implement AI-driven medication management system
- Tennessee dental practice to close due to financial strain
- Listen to the Latest ‘KFF Health News Minute’
- Lifepoint Health taps new vice president of finance from Acadia
- UnitedHealthcare to reduce prior auth requirements by 30%
- ‘Retire one-and-done interventions’: Wellstar achieves 40% drop in physician distress
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Why state dental boards are scrutinizing DSOs
- Child Mind Institute names chief clinical officer
- UMass Memorial behavioral health provider to lay off 78 employees
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- American Hospital Association, West Health Institute partner to help health systems scale new tech
- Alignment CEO expects short delay for CMS' proposed risk adjustment changes
- WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Nearly half of reproductive age women with Medicaid coverage live in states restricting abortion: KFF
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
- After March cuts, Novartis trims another 60 roles at US headquarters
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
- Orchestrating Affordability: The Critical New Role of the Health Plan
- The Case for a More Proactive Payment Integrity Program
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
This is how you get your Cabinet nominees confirmed, double quick time, without histrionics. The Democrats stalling RFK, Jr. just ran out of slack. From Gizmodo, a mouthpiece of the left:
https://gizmodo.com/trump-orders-cdc-fda-and-other-health-agencies-to-go-dark-2000553437
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The communications pause could be an early sign of things to come under a renewed Trump White House.
By Ed Cara | January 22, 2025The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the U.S. Department of Health and Human Services. This week, the returning Trump administration told these agencies to stop talking to the public—for how long, no one knows.
The Washington Post first broke news of Trump’s sweeping directive late Tuesday evening. Staff at these agencies have been reportedly ordered to cease external communication for the time being. The move is the latest to unnerve outside experts about the direction of the country’s public health infrastructure under Trump.
The order was delivered by Stefanie Spear, a newly hired deputy chief of staff at HHS, according to the Post. Spear was the press secretary for Robert F. Kennedy Jr. during his 2024 presidential campaign, who has since been nominated by Trump to lead HHS. Affected staff told the Post that the directive lacked specific details, including the reasoning behind it, how long the pause is expected to last, and whether there are any exceptions allowed.
Gizmodo reached out to the HHS for comment but did not hear back by the time of publication.
It’s certainly possible that the White House is simply trying to make it easier for its new health officials to transition into their roles. And this isn’t an unprecedented action for the White House to take to accomplish that, according to Carmen Marsit, executive associate dean at Emory University’s Rollins School of Public Health.
“It is not uncommon for a new administration to ask for a pause on communications, website updates, etc, in order for new leadership to review the information, understand how information flows, and then work to continue communications,” Marsit told Gizmodo in an email. At the same time, he added, the scope of this directive is currently unknown, as is its potential impact on the public.
Emerging outbreaks, new discoveries, and noteworthy drug approvals are just some of the many things that agencies like the CDC and FDA regularly communicate to the general public and clinicians. Research led by or conducted with the help of government scientists is also routinely published in the CDC’s Morbidity and Mortality Weekly Report (MMWR), which has often served as an early look into important health trends and crises (the first reported cases of what came to be known as HIV/AIDS, for instance). According to the Post, CDC staff were planning to publish several reports in the MMWR this week, including three concerning H5N1—a highly pathogenic strain of avian influenza that has increasingly started to infect cattle, other mammals, and humans since last year.
Halting communication from federal health agencies like the CDC, NIH, and FDA during an administration transition is highly problematic, especially with active public health threats like the H5N1 outbreak in the U.S. and the Marburg outbreak in Tanzania, according to Krutika Kuppalli, an infectious disease physician in Dallas with experience in global health and pandemic preparedness.
“A blanket suspension of external communication from health agencies is unusual and potentially harmful,” Kuppalli told Gizmodo. “Trust in institutions like the CDC is built on transparency and reliability. A lack of communication could lead to skepticism or distrust, making it harder to re-establish credibility when communication resumes.”
There’s also past history to consider, as the Trump-led White House has a track record of muzzling its federal agencies and scientists. In the early days of Trump’s first term, the administration similarly ordered several agencies, including the United States Department of Agriculture, to temporarily stay quiet (much of this directive was quickly revised, however). More worryingly, the Trump administration prevented health officials from communicating with the press and public in the early months of the covid-19 pandemic, while his staff reportedly later tried to alter reports from the CDC concerning covid-19—allegedly with the goal of downplaying the harms of the pandemic.
The potential next leader of HHS, RFK Jr., has also made it clear that he wants to dramatically change the direction of the country’s public health agencies, and likely not for the better. RFK Jr. has regularly espoused false or misleading statements about vaccines and other health-related topics, for instance, and he’s promised to suspend government-led research on infectious diseases if given the chance. And earlier this week, Trump signed an executive order reinstating his plan to have the U.S. leave the World Health Organization, which has played a vital role in supporting public health globally.
“The CDC collaborates with international partners to tackle global health challenges,” noted Kuppalli, who has previously worked with the WHO as a medical officer on covid-19. “The planned withdrawal from WHO already has implications for the U.S.’ role in global health, but a communication freeze could further undermine the U.S.’ reputation as a leader in public health.”
Should this pause linger on, it may be an early indication that the CDC and other agencies will face new challenges from the Trump administration that might prevent them from communicating honestly with the public. And that’s likely to bode very badly for the rest of us.
“While it is the prerogative of any administration to align federal agencies with their vision and goals, public health must remain a nonpartisan priority,” Kuppalli said. “Ensuring continuity of communication from agencies like the CDC, FDA and NIH during transitional periods is not only wise but essential for safeguarding the health and well-being of the public.”
Federal health employee travel has been curtailed. Participation in and sponsorship of external meetings has also been suspended:
US health agencies cancel external meetings, travel after Trump admin directives
By Julie Steenhuysen - January 23, 2025Summary
* 'One Health' bird flu call canceled this week -source
* Travel ban enacted for all health agency employees
* CDC weekly publication of scientific reports did not publish on ThursdayCHICAGO, Jan 23 (Reuters) - U.S. health agencies including the CDC this week canceled meetings with external groups, paused some public health publications and told employees to freeze travel after directives from the Department of Health and Human Services, two sources familiar with the situation said.
On Wednesday, a state/federal call scheduled for Thursday involving states affected by H5N1 bird flu in dairy cattle and other animals was canceled, one of the sources said. It also postponed a training session for public health practitioners, the source said.
The source said the H5N1 bird flu calls occur on a regular schedule, and was aware only that the Thursday session, which was designated a "One Health" call involving both human and animal health issues, was canceled.
Presidential transitions often involve some pause in communications but the source characterized the current scope as broad.
South Dakota's state veterinarian Beth Thompson confirmed that the Centers for Disease Control and Prevention on Wednesday canceled an upcoming, regularly scheduled call with state veterinarians that would normally focus on bird flu. "There was no reason given," she said.
However, the U.S. Department of Agriculture did hold a regularly scheduled call on Wednesday on tracing the location of diseased or at-risk animals through its Veterinary Services program, Thompson said.
Scientists and public health officials are growing increasingly concerned about the spread of H5N1 bird flu, which has infected nearly 70 people in the U.S. since April. Most cases have been mild and occurred in farm workers, according to the CDC.
Earlier this month, however, the United States reported its first death from bird flu after an older person was exposed to a combination of backyard chickens and wild birds.
The cancellations followed a memo from acting HHS Secretary Dorothy Fink seen by Reuters that called for an immediate pause on issuing documents and public communications, including on any speaking engagements until the material has been reviewed and approved by a presidential appointee.
The pause is intended to extend through Feb. 1.
HHS said in a statement that its pause was for public communications not directly related to emergencies or critical to preserving health, and said exceptions for mission critical communications would be made on a case-by-case basis.
A travel ban directive was sent in a Jan. 21 memo to financial officers and travel officials within all operating divisions of HHS, including the National Institutes of Health, the Food and Drug Administration and the CDC, according to an HHS official who was not authorized to speak publicly on the matter.
The travel ban is in effect until further notice, according to the HHS official, who read portions of the memo to Reuters.
It specifies that any speaking engagements that had been accepted prior to Jan. 20 must be canceled.
Travel is only authorized for people who have already departed on an official trip, and the traveler must return to the original point of departure.
Employees from the Indian Health Service are exempted from the suspension.
While a few health communications have been issued since the ban – the FDA on Wednesday put out details of a new safety warning on a drug, for instance – others were canceled.
FIRST PAUSE SINCE 1960
The CDC's Morbidity and Mortality Weekly report, or MMWR, which includes scientific reports from the agency and outside scientists, was not published on Thursday as planned. HHS did not comment on when publication would resume.
In a post on X, former CDC director Dr. Tom Frieden said the MMWR, which is used to inform health officials about emerging threats, had been published weekly without pause since 1960. Delays in its publication put Americans' health at risk, Frieden said.
Dr. Jeremy Faust, a Boston-based emergency physician and author of the Inside Medicine newsletter published on the Substack platform, said the NIH was told to halt the process that approves funding for new scientific and medical research, citing an email shown to him by an NIH official.
The memo noted that all such advisory meetings had been canceled, but noted that such work would be rescheduled.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














